AU2001273235A1 - Lipid metabolism molecules - Google Patents

Lipid metabolism molecules

Info

Publication number
AU2001273235A1
AU2001273235A1 AU2001273235A AU7323501A AU2001273235A1 AU 2001273235 A1 AU2001273235 A1 AU 2001273235A1 AU 2001273235 A AU2001273235 A AU 2001273235A AU 7323501 A AU7323501 A AU 7323501A AU 2001273235 A1 AU2001273235 A1 AU 2001273235A1
Authority
AU
Australia
Prior art keywords
lipid metabolism
metabolism molecules
molecules
lipid
metabolism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273235A
Inventor
Chandra S Arvizu
Yalda Azimzai
Mariah R. Baugn
Narinder K. Chawla
Debopriya Das
Vicki S. Elliott
Ameena R. Gandhi
April J. A. Hafalia
Farrah A. Khan
Preeti Lal
Dyung Aina M. Lu
Yan Lu
Danniel B. Nguyen
Jayalaxmi Ramkumar
Y. Tom Tang
Michael Thornton
Catherine M. Tribouley
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2001273235A1 publication Critical patent/AU2001273235A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001273235A 2000-07-07 2001-07-06 Lipid metabolism molecules Abandoned AU2001273235A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US21680100P 2000-07-07 2000-07-07
US21680300P 2000-07-07 2000-07-07
US60/216,803 2000-07-07
US60/216,801 2000-07-07
US21823300P 2000-07-14 2000-07-14
US60/218,233 2000-07-14
US22004600P 2000-07-21 2000-07-21
US60/220,046 2000-07-21
US22073900P 2000-07-26 2000-07-26
US60/220,739 2000-07-26
US22282400P 2000-08-04 2000-08-04
US60/222,824 2000-08-04
PCT/US2001/021432 WO2002004490A2 (en) 2000-07-07 2001-07-06 Lipid metabolism molecules

Publications (1)

Publication Number Publication Date
AU2001273235A1 true AU2001273235A1 (en) 2002-01-21

Family

ID=27559093

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273235A Abandoned AU2001273235A1 (en) 2000-07-07 2001-07-06 Lipid metabolism molecules

Country Status (5)

Country Link
EP (1) EP1313857A2 (en)
JP (1) JP2004519207A (en)
AU (1) AU2001273235A1 (en)
CA (1) CA2414219A1 (en)
WO (1) WO2002004490A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034627A1 (en) * 1999-11-12 2001-05-17 Human Genome Sciences, Inc. 28 human secreted proteins
US7258855B2 (en) 2000-09-19 2007-08-21 Kyowa Hakko Kogyo Co., Ltd. Polypeptides having phospholipase A2 activity
AU2002212318A1 (en) * 2000-10-10 2002-04-22 Bayer Aktiengesellschaft Regulation of human phospholipase a2-like enzyme
AU2001283321A1 (en) 2000-11-08 2002-05-21 Millennium Pharmaceuticals, Inc. A human phospholipase c and uses thereof
WO2003060132A1 (en) * 2002-01-17 2003-07-24 Tanabe Seiyaku Co., Ltd. Novel phospholipase a2 and gene thereof
AU2003221383A1 (en) * 2002-03-14 2003-09-22 Kyowa Hakko Kogyo Co., Ltd. Preventives or remedies for dermatitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4739501A (en) * 2000-03-13 2001-09-24 Lexicon Genetics Inc Novel human phospholipases and polynucleotides encoding the same
US6958152B2 (en) * 2000-04-29 2005-10-25 Merck Patent Gmbh Human phospholipase C delta 5

Also Published As

Publication number Publication date
WO2002004490A2 (en) 2002-01-17
EP1313857A2 (en) 2003-05-28
CA2414219A1 (en) 2002-01-17
WO2002004490A3 (en) 2003-03-20
JP2004519207A (en) 2004-07-02

Similar Documents

Publication Publication Date Title
AU2001277969A1 (en) Direct internet advertising
AU2001280710A1 (en) Internet advertising
AU4211600A (en) Modified lipid production
AU2002359949A1 (en) Compositions for improving lipid metabolism
AUPQ339899A0 (en) Novel molecules
AU2001264055A1 (en) Display assembly
AU2002245332A1 (en) Anergy-regulated molecules
AU2002337312A1 (en) Molecules
AU2001281636A1 (en) Advertising
AU5018900A (en) Lipid metabolism transcription factor
AU2001231053A1 (en) Lipid metabolism enzymes
AU2002217384A1 (en) Anti-allergic complex molecules
AU2001273235A1 (en) Lipid metabolism molecules
AU2001294245A1 (en) Compositions for improving lipid metabolism
AU2001287022A1 (en) Secretory molecules
AU2001245397A1 (en) Lipid metabolism enzymes
AU2002211005A1 (en) Lipid peroxide-lowering compositions
AU2002239632A1 (en) Display housing
AU2001257427A1 (en) Rna metabolism proteins
AU2001261424A1 (en) Lipid metabolism enzymes
AU2001230342A1 (en) Display unit
AU2001236631A1 (en) Secretory molecules
AUPQ900200A0 (en) Display means
AU2001286678A1 (en) Lipid metabolism enzymes
AU2002224352A1 (en) Lipid metabolism enzymes